MRK  Merck & Company Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

174.03B

Vuru Grade

54.36/100

Current Price

$62.94
-0.645 (-1.014%)

Growth Price

$54.47
Overvalued by 13.45%

Stability Price

$20.53
Overvalued by 67.38%

Company Metrics

  • P/E 34.523
  • P/S 4.457
  • P/B 4.056
  • EPS 1.823
  • Cash ROIC 12.97%
  • Cash Ratio 0.70
  • Dividend 1.84 / 2.9%
  • Avg. Vol. 9.89M
  • Shares 2.77B
  • Market Cap. 174.03B

Company Description

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, ... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Merck & Co., Inc. Features Slow and Steady Dividend Growth (MRK)
Investorplace.com - 15 hours ago
Merck & Co., Inc. (MRK) is a blue-chip dividend stock that has paid a consistent dividend since 1970 and has grown its dividend at a 1.8% annual rate over the last 10 years.
Merck, UnitedHealth Sink DJIA Wednesday
24/7 Wall St. - 12 hours ago
Merck & Co. Inc. (NYSE: MRK) traded down 1.39% at $62.69. The stock's 52-week range is $47.97 to $64.00. Trading volume was about half the daily average of around 9.9 million.
Merck & Co., Inc. (MRK): Slow And Steady Dividend Growth
ValueWalk - Aug 23, 2016
Merck is a blue-chip dividend stock that has paid a consistent dividend since 1970 and has grown its dividend at a 1.8% annual rate over the last 10 years.
Merck & Co., Inc. (NYSE:MRK) Stock Rises, Analysts: Hold Rating
Review Fortune - 14 hours ago
Merck & Co., Inc. (NYSE:MRK) up 0.86% for the past 5 days, is under coverage of 22 analysts who collectively assign a hold rating on stock.
Merck & Co., Inc. (MRK) Preps for a Healthy Breakout - Investorplace.com
Analysts Valuations For Two Stocks: Merck & Co., Inc. (NYSE:MRK), Mondelez ... - The Voice Registrar
Better Buy: Merck & Co. Inc. vs. Eli Lilly
Motley Fool - Aug 4, 2016
Over the past decade, the iShares U.S. Pharmaceuticals ETF has risen a stunning 211%, trouncing the broad market S&P 500 benchmark's gain of about 70% over the same period.
Merck & Company Inc. (new) (MRK) Closes 1.34% Down on the Day for August 24
Equities.com - 10 hours ago
Dow Jones component Merck & Company Inc. (new) (MRK) saw its stock move -1.34% to $62.73, representing a per-share move of $0.85, on volume of 7.43 million shares for Wednesday.
Merck & Co., Inc. (NYSE:MRK): Updated Analyst Ratings
Review Fortune - Aug 17, 2016
Merck & Co., Inc. (NYSE:MRK) up 0.88% for the past 5 days, is under coverage of 22 analysts who collectively assign a hold rating on stock.
Merck & Co., Inc. (NYSE:MRK)'s MSD Selling Primary Care Drugs - Market Exclusive
Analysts Recommendation on Merck & Co., Inc. (NYSE:MRK) - Post Registrar
Soaring Merck & Co., Inc. (MRK) Sets Options Pits on Fire
Schaeffers Research (blog) - Aug 5, 2016
Drugmaker and Dow component Merck & Co., Inc. (NYSE:MRK) is flying high today, leading the blue-chip index higher, as it benefits from a competitor's disappointment.
Merck & Co., Inc. (NYSE:MRK) Analyst Opinion - Zergwatch
Why EOG Resources Inc (EOG), Merck & Co., Inc. (MRK) and Rackspace Hosting ...
Investorplace.com - Aug 5, 2016
Why EOG Resources Inc (EOG), Merck & Co., Inc. On the back of that news, the S&P 500 Index climbed 0.86% while the Dow Jones Industrial Average rose 1.04%.
Identifying Analyst Research Reports To Consider: Merck & Co., Inc. (NYSE:MRK ...
Review Fortune - Aug 19, 2016
Merck & Co., Inc. (NYSE:MRK) remained bullish with an increase +0.54% putting the price on the $63.63 per share in last trading session ended on 8/18/2016.